Article information
Full text is only aviable in PDF
Bibliografía
[1.]
A. Hebrero.
Medicina Aeronáutica. Evolución histórica y su vinculación con la seguridad en vuelo.
AEROECA, 1 (1991), pp. 37-38
[2.]
H. Gong Jr..
Air travel and oxygen therapy in cardiopulmonary patients.
Chest, 101 (1992), pp. 1.104-1.113
[3.]
S. Tomas, A. Blanes.
Actuaciones y limitaciones humanas en aviación civil.
TADAIR, S.A, (1993),
[4.]
F. Smeets.
Pulmonary rehabilitation in chronic respiratory insufficiency.
6. Travel for technology-dependent patients with respiratory disease. Thorax, 49 (1994), pp. 77-81
[5.]
J.J. Cottrell.
Altitude exposures during aircraft flight.
Flying higher. Chest, 92 (1988), pp. 81-84
[6.]
J.A. Aldrete, L.E. Aldrete.
Oxygen concentrations in commercial aircraft flights.
South Med J, 76 (1983), pp. 12-14
[7.]
Code of Federal Regulations, Title 14, CF.R., Part, 25. 841.
US Government Printing Office, (1986),
[8.]
Cardiovascular Commitee, Cystic Fibrosis Foundation.
Airline travel for children with chronic pulmonary disease.
Pediatrics, 57 (1976), pp. 408-410
[9.]
H. Gong Jr..
Advising pulmonary patients about commercial air travel.
J Respir Dis, 11 (1990), pp. 484-499
[10.]
AMA., Commission on Emergency Medical Services.
Medical aspects of transportation aboard commercial aircraft.
JAMA, 247 (1982), pp. 1.007-1.011
[11.]
U.C. Luft.
Aviation physiology. The effects of altitude.
Handbook of Physiology; sección 3: Respiration., pp. 1.099-1.145
[12.]
R.A. McFarland.
Human factors in relationship to the development of pressurized cabins.
Aerospace Med, 12 (1971), pp. 1.3031.318
[13.]
C. Lenfant, K. Sullivan.
Adaptation to high altitude.
N Engl J Med, 284 (1971), pp. 1.298-1.309
[14.]
California Thoracic Society.
Travel at high altitude: information for physicians.
American Lung Association of California, (1989),
[15.]
L. Cudowicz.
Mean pulmonary artery pressure and alveolar oxygen tension in man at different altitudes.
Respiration, 27 (1970), pp. 417-430
[16.]
G.R. Kelman, T.J. Crow.
Impairment of mental performance at a simulated altitude of 8.000 feet.
Aerospace Med, 40 (1969), pp. 981-982
[17.]
F.J. Mills, R.M. Harding.
Fitness to travel by air I: Physiological considerations.
Br Med J, 286 (1983), pp. 1.269-1.271
[18.]
G.C. Scott, R. Berger, H.E. McKean.
The role of atmospheric pressure variation in the development of spontaneus pneumothoraces.
Am Rev Respir Dis, 139 (1989), pp. 659-662
[19.]
J.E.P. Thomas, C.P. Abson, N.J.W. Cairns.
Pulmonary embolism. A hazard of air travel.
Cent Afr J Med, 27 (1981), pp. 85-87
[20.]
I.A. Symington, B.H.R. Stack.
Pulmonary thromboembolism after travel.
Br J Dis Chest, 71 (1977), pp. 138-140
[21.]
J. Holliday.
Atypical presentation of múltiple pulmonary emboli in a young air traveller.
J R Coll Gen Pract, 35 (1985), pp. 497
[22.]
J.M. Cruickshank, R. Gorlin, B. Jennett.
Air travel and thrombotic episodes.
The economy class syndrome. Lancet, 2 (1988), pp. 497-498
[23.]
S. Finkelstein, J.F. Tomashefski, F.H. Shillito.
Pulmonary mechanics at altitude in normal and obstructive lung disease patients.
Aerospace Med, 36 (1965), pp. 880-884
[24.]
G. Coates, G. Gray, A. Mansell, C. Nahmias, A. Powles, J. Sutton, et al.
Changes in lung volume, lung density, and distribution of ventilation during hypobaric decompression.
J Appl Physiol, 46 (1979), pp. 752-755
[25.]
M.J. Parkhust, S.A. Leverett, S.J. Shubrooks.
Human tolerance to high sustained +GZ accelerations.
Aerospace Med, 43 (1972), pp. 1.200-1.206
[26.]
R.A. Burton, S.A. Leverett, E.D.J. Michaelson.
Man at high sutained +Gz acceleration: a review.
Aerospace Med, 45 (1974), pp. 1.115-1.136
[27.]
J. Desola Alá.
Enfermedad descompresiva.
JANO, 382 (1979), pp. 49-62
[28.]
B. Grandjean, B. Taffani.
Quelques remarques á propos de l’évolution clinique d’une surpression pulmonaire.
Med Aer Spat Med Sub Hyp, 7 (1988), pp. 107-111
[30.]
G.R. Davies, P.R. Degotardi.
Inflight medical facilities.
Aviat Space Environ Med, 53 (1982), pp. 694-700
[31.]
R.O. Cummins, P.J.C. Chapman, D.A. Chamberlain, J.A. Schubach, P.E. Litwin.
Inflight deaths during commercial air travel: how big is the problem?.
JAMA, 259 (1988), pp. 1.983-1.988
[32.]
R. Sarvesvaran.
Sudden natural deaths associated with commercial air travel.
Med Sci Law, 26 (1986), pp. 35-38
[33.]
J.J. Cottrell, J.T. Callaghan, G.M. Kohn, E.C. Hensler, R.M. Rogers.
Inflight medical emergencies.
One year of experience with the enhanced medical kit. JAMA, 262 (1989), pp. 1.653-1.656
[34.]
J.R. Hordinsky, M.H. George.
Response capability during civil air carrier inflight medical emergencies.
Aviat Space Environ Med, 60 (1989), pp. 1.211-1.214
[35.]
O.W. Skjenna, J.F. Evans, M.-S. Moore, C. Thibeault, A.G. Tucker.
Helping patients travel by air.
Canad Med Assoc J, 144 (1991), pp. 287-293
[36.]
R.O. Cummins, J.A. Schubach.
Frequency and types of medical emergencies among commercial air travelers.
JAMA, 261 (1989), pp. 1.295-1.299
[37.]
C. Speizer, C.J. Rennie III, H. Breton.
Prevalence on in-flight medical emergencies on commercial airlines.
Ann Emerg Med, 18 (1989), pp. 26-29
[38.]
R. Iglesias, M.D.C.G. Cortes, C. Almanza.
Facing air passengers medical problems while on board.
Aerospace Med, 45 (1974), pp. 204-206
[39.]
H. Gong Jr., D.P. Tashkin, E.Y. Lee, M.S. Simmons.
Hypoxiaaltitude simulation test.
Evaluation of patients with chronic airway obstruction. Am Rev Respir Dis, 130 (1984), pp. 980-986
[40.]
Committee on Medical Criteria of Aerospace Medical Association.
Medical criteria for passenger flying: scheduled commercial flights.
Arch Environ Health, 2 (1961), pp. 124-138
[41.]
F.J. Mills, R.M. Harding.
Fitness to travel by air II: specific medical considerations.
Br Med J, 186 (1983), pp. 1.340-1.341
[42.]
B.W. Berg, T.A. Dillard, S.S. Derderian, K.R. Rajagopal.
Hemodynamic effects of altitude exposure and oxygen administration in chronic obstructive pulmonary disease.
Am J Med, 94 (1993), pp. 407-412
[43.]
T.A. Dillard, B.W. Berg, K.R. Rajagopal, J.W. Dooley, W.A. Mehn.
Effect of altitude exposure on pulmonary function in chronic airway obstruction (CAO) [resumen].
Am Rev Respir Dis, 139 (1989), pp. 296
[44.]
J.S. Schwartz, H.Z. Bencowitz, K.M. Moser.
Air travel hypoxemia with chronic obstructive pulmonary disease.
Ann Intern Med, 100 (1984), pp. 473-477
[45.]
J.F. Tomashefski, F.H. Shillito, C.E. Billings, W.F. Ashe.
Effects of moderate altitude on patients with pulmonary and cardiac impairment.
Calif Med, 101 (1964), pp. 358-362
[46.]
N.R. Anthonisen.
Long-term oxygen therapy.
Ann Intern Med, (1983), pp. 519-527
[47.]
American Thoracic Society.
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma.
Am Rev Respir Dis, 136 (1987), pp. 225-234
[48.]
H. Gong Jr., J.A. Lee Mark, M.N. Cowan.
Preflight medical screenings of patients.
Analysis of health and flight characteristics. Chest, 104 (1993), pp. 788-794
[49.]
T.A. Dillard, W.A. Beninati, B.W. Berg.
Air travel in patients with chronic obstructive pulmonary disease.
Arch Intern Med, 151 (1991), pp. 1.793-1.795
[50.]
J.N. Henry, L.F. Krenis, R.T. Cutting.
Hypoxemia during aeromedical evacuation.
Surg Gynecol Obstet, 136 (1973), pp. 49-53
[51.]
H. Matthys, H. Volz, H. Ernst, N. Konietzko, H.R. Kleeberg.
Kardiopulmonale belastung von flugpassagieren mit obstruktiven ventilationsstórungen.
Schweiz Med Wochenschr, 104 (1974), pp. 1.491-1.494
[52.]
F.H. Shillito, J.F. Tomashefski, W.H. Ashe.
The exposure of ambulatory patients to moderate altitudes.
Aerospace Med, 34 (1963), pp. 850-857
[53.]
P.N. Mathur, I.R.G. Dowdeswell, R.B. Stonehill.
A method to assess and prescribe controlled oxygen therapy during commercial air travel [resumen].
Am Rev Respir Dis, 129 (1984), pp. 51
[54.]
T.A. Dillard, B.W. Berg, K.R. Rajagopal, J.W. Dooley, W.J. Mehm.
Hypoxemia during air travel in patients with chronic obstructive pulmonary disease.
Ann Intern Med, 111 (1989), pp. 362-367
[55.]
T.A. Dillard, A.P. Rosenberg, B.W. Berg.
Hypoxemia during altitude exposure. A meta-analysis of chronic obstructive pulmonary disease.
Chest, 103 (1993), pp. 422-425
[56.]
H. Gong Jr..
Air travel and patients with chronic obstructive pulmonary disease.
Ann Intern Med, 100 (1984), pp. 595-597
[57.]
B.W. Berg, T.A. Dillard, K.R. Rajagopal, W.J. Mehm.
Oxygen supplementation during air travel in patients with chronic obstructive lung disease.
Chest, 101 (1992), pp. 638-641
[58.]
H. Gong Jr..
Advising patients with pulmonary diseases on air travel.
Ann Intern Med, 111 (1989), pp. 349-351
[59.]
J.K. Stoller.
Travel for the technology-dependent individual.
Respir Care, 39 (1994), pp. 347-362
[61.]
Dillard TA. Dietary carbohydrate, alveolar gas, and chronic obstructive pulmonary disease. Ann Intern Med 112: 309-310.
[62.]
K.P. Vohra, R.A. Klocke.
Detection and correction of hypoxemia associated with air travel.
Am Rev Respir Dis, 148 (1993), pp. 1.215-1.219
[63.]
T.A. Dillard, L.K. Moores, K.L. Bilello, Y.Y. Phillips.
The preflight evaluation. A comparison of the hypoxia inhalation test with hipobaric exposure.
Chest, 107 (1995), pp. 352-357
[64.]
K.L. Christopher.
Travel for patients with chronic respiratory disease.
Foundations of respiratory care., pp. 1.175-1.184
[65.]
Medical Research Council Working Party.
Long-term domiciliary oxygen therapy in chronic cor pulmonale complicating chronic bronchitis and emphysema, 1 (1981), pp. 681-685
Copyright © 1995. Sociedad Española de Neumología y Cirugía Torácica
